




Searching News Database: radiopharmaceuticals
HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
HSMN NewsFeed - 23 Jul 2021
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
ImaginAb Announces Extension Of Long-Standing Partnership With Boehringer Ingelheim
HSMN NewsFeed - 9 Jun 2021
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
Lightpoint Medical Expands Executive Leadership Team with Appointment of Graeme Smith to CEO
HSMN NewsFeed - 27 Jun 2019
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
Bracco Imaging Expands Portfolio of Personalized Diagnostics With the Acquisition of Blue Earth Diagnostics
HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
HSMN NewsFeed - 9 Jun 2016
NuView Life Sciences Appoints Joel R. Timberlake as President of US Radiopharmaceuticals
NuView Life Sciences Appoints Joel R. Timberlake as President of US Radiopharmaceuticals
HSMN NewsFeed - 13 May 2015
Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development
Jeng-Dar Yang Ph.D. Joins Actinium Pharmaceuticals as Vice President of Pharmaceutical Development
HSMN NewsFeed - 7 Jan 2014
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
Navidea Biopharmaceuticals Expands Lymphoseek(R) Global Commercialization Efforts
HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
HSMN NewsFeed - 18 Sep 2013
Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
Actinium Pharmaceuticals Appoints Corey Sohmer As Vice President Of Finance And Business Development
HSMN NewsFeed - 25 Jun 2013
IsoRay Announces a New International Distributor in Australia and New Zealand
IsoRay Announces a New International Distributor in Australia and New Zealand
HSMN NewsFeed - 21 Mar 2013
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
Results of Lymphoseek(R) Phase 3 Clinical Trials in Breast Cancer Published in Annals of Surgical Oncology
HSMN NewsFeed - 28 Oct 2012
IBA and Philips Announce First Installation of Patient-Centered Proton Treatment Room
IBA and Philips Announce First Installation of Patient-Centered Proton Treatment Room
HSMN NewsFeed - 5 Dec 2011
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
INSYS Therapeutics Announces Addition of VP of Marketing to Commercial Team
HSMN NewsFeed - 18 Mar 2011
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
HSMN NewsFeed - 16 Sep 2010
FluoroPharma Inc. Appoints Mr. Thijs Spoor as Chief Executive Officer and Director
FluoroPharma Inc. Appoints Mr. Thijs Spoor as Chief Executive Officer and Director
HSMN NewsFeed - 14 Apr 2010
Hybridyne Imaging Technologies Receives FDA Clearance for New Medical Imaging System
Hybridyne Imaging Technologies Receives FDA Clearance for New Medical Imaging System
HSMN NewsFeed - 6 Jul 2009
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
Covidien Announces Health Canada Approval for its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 30 Apr 2009
Positron Joint Venture Receives FDA Approval for Attrius(TM) Scanner Product Line
Positron Joint Venture Receives FDA Approval for Attrius(TM) Scanner Product Line
HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
HSMN NewsFeed - 3 Nov 2008
Covidien and PETNET Solutions Enter Co-Marketing Agreement for Nuclear Medicine Products
Covidien and PETNET Solutions Enter Co-Marketing Agreement for Nuclear Medicine Products
HSMN NewsFeed - 23 Sep 2008
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
Covidien Announces FDA Approval for its Generic Myocardial Perfusion Imaging Kit
HSMN NewsFeed - 22 Sep 2008
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
Molecular Insight Pharmaceuticals, Inc. Adds Four Healthcare Industry Experts to Board of Directors
HSMN NewsFeed - 13 Jun 2008
Positron Corporation Announces Sales & Marketing Agreement with NuView Radiopharmaceuticals
Positron Corporation Announces Sales & Marketing Agreement with NuView Radiopharmaceuticals
HSMN NewsFeed - 8 Jan 2008
DRAXIS Names New President and Chief Executive Officer as well as New Chief Operating Officer
DRAXIS Names New President and Chief Executive Officer as well as New Chief Operating Officer
HSMN NewsFeed - 21 Dec 2007
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
GE Healthcare Announces Expansion of Nuclear Cardiology Portfolio for Medical Diagnostics Business
HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
HSMN NewsFeed - 4 Jun 2007
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
Avid Radiopharmaceuticals Appoints Ernest Mario, Ph.D. to Board of Directors
HSMN NewsFeed - 29 May 2007
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
DRAXIS Appoints Bruce DeChambre to Head Business Development for Contract Manufacturing Division
HSMN NewsFeed - 19 Mar 2007
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting
HSMN NewsFeed - 2 Feb 2007
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
DRAXIS Radiopharmaceuticals Division Applies to FDA to Market Cardiac Imaging Product
HSMN NewsFeed - 3 Jan 2007
Mallinckrodt Signs New Imaging and Radiopharmaceutical Agreements With Premier Purchasing Partners
Mallinckrodt Signs New Imaging and Radiopharmaceutical Agreements With Premier Purchasing Partners
HSMN NewsFeed - 18 Dec 2006
American Cancer Society Journal Article Reports New Data Regarding Repeated Administration of QUADRAMET(R)
American Cancer Society Journal Article Reports New Data Regarding Repeated Administration of QUADRAMET(R)
HSMN NewsFeed - 27 Nov 2006
Spectrum Dynamics Receives 510(K) Clearance for the D-SPECT(TM) Cardiac System
Spectrum Dynamics Receives 510(K) Clearance for the D-SPECT(TM) Cardiac System
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
HSMN NewsFeed - 27 Jul 2006
Premier Inc. Announces Imaging Group Buy With Philips Medical, Mallinckrodt, and Medrad
Premier Inc. Announces Imaging Group Buy With Philips Medical, Mallinckrodt, and Medrad
HSMN NewsFeed - 6 Jul 2006
Cardinal Health Acquires Positron Emission Tomography (PET) Radiopharmaceutical Production Facilities
Cardinal Health Acquires Positron Emission Tomography (PET) Radiopharmaceutical Production Facilities
HSMN NewsFeed - 5 Jun 2006
GE Healthcare Initiates Clinical Trials for First-Ever PET Imaging Agent to Track Angiogenesis in Cancer
GE Healthcare Initiates Clinical Trials for First-Ever PET Imaging Agent to Track Angiogenesis in Cancer
HSMN NewsFeed - 22 May 2006
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Xanthus Pharmaceuticals Appoints John Lister-James, Ph.D. as Vice President, Development
Additional items found! 96

Members Archive contains
96 additional stories matching:
radiopharmaceuticals
(Password required)
radiopharmaceuticals
(Password required)